Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
American chemical industry news
(page 21)
20 October 2025
Roche's Gazyva Approved by FDA for Lupus Nephritis Treatment
FDA approves Gazyva for lupus nephritis, showing superior results in trials, offering a new treatment option to prevent kidney disease progression.
19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
18 October 2025
Merck's KEYTRUDA Plus Chemotherapy Reduces Disease Progression Risk in Platinum-Resistant Ovarian Cancer
KEYTRUDA with chemotherapy shows significant survival benefits in platinum-resistant ovarian cancer, leading to FDA priority review for expanded use.
17 October 2025
Roche Unveils Phase III Data for Vamikibart in Uveitic Macular Edema
Vamikibart shows promise in treating UME, with significant vision improvements in trials, offering a non-steroid alternative with fewer side effects.
17 October 2025
FDA Approves Novo Nordisk's Oral Semaglutide for CV Risk Reduction in High-Risk Type 2 Diabetes Adults
Oral semaglutide reduces major cardiovascular events in high-risk type 2 diabetes patients, showing a 14% risk reduction over 4 years, with consistent safety profile.
How does the American chemical industry perform?
Find out with
chemXplore Alpha
Learn more
17 October 2025
Roche's Gazyva/Gazyvaro Gains EU CHMP Nod for Lupus Nephritis
CHMP backs Gazyva/Gazyvaro for lupus nephritis, showing superior renal response in trials. Awaiting European Commission decision.
17 October 2025
Mitsubishi Gas Chemical and Cirena Agree on Japan Distribution for Long-Chain RNA
MGC and Cirena to negotiate exclusive Japan distribution for long-chain RNA, enhancing MGC's nucleic acid pharmaceutical efforts.
16 October 2025
BASF Launches High-Purity Isobionics® Natural Lime Flavor Ingredient
Isobionics® Natural alpha-Farnesene 95 offers high purity for lime applications, is fermentation-based, and meets EU/US food regulations. Suitable for beverages, sweets, and citrus flavors.
16 October 2025
Aptar Digital Health's HeroTracker Sense Gains FDA 510(k) Clearance
HeroTracker Sense, a Bluetooth sensor for inhalers, gets FDA clearance, enhancing asthma and COPD management with real-time tracking and personalized support for patients aged 12 and above.
16 October 2025
Johnson & Johnson's AKEEGA® Gets FDA Priority Review for BRCA-Mutated Prostate Cancer
FDA grants Priority Review to AKEEGA® for BRCA-mutated prostate cancer, showing reduced progression risk and improved outcomes in Phase 3 study.
16 October 2025
Merck's KEYNOTE-B96 Trial Shows Improved Survival in Platinum-Resistant Ovarian Cancer
The trial showed improved overall survival with KEYTRUDA in platinum-resistant ovarian cancer, with consistent safety and no new signals. Results to be presented at a future medical meeting.
15 October 2025
Novo Nordisk Acquires Rights to Omeros' MASP-3 Inhibitor Zaltenibart
Zaltenibart, a MASP-3 inhibitor, targets rare blood and kidney disorders. Omeros receives up to $2.1 billion, plus royalties. Novo Nordisk plans global phase 3 trials.
15 October 2025
BASF Launches Ameriflor Calm for Sensitive Skin
Ameriflor Calm, a plant-based ingredient, enhances skin resilience, reduces redness, and is sustainably sourced and produced using renewable energy.
14 October 2025
BASF Launches Sustainable Nylon 6 Solutions in North America
BASF introduces Ultramid LowPCF and BMB, reducing carbon footprints by up to 50% using renewable natural gas, supporting sustainability without altering existing operations.
14 October 2025
BASF's Zorina Fungicide Gains EPA Approval
Zorina fungicide, combining Endura and Revysol, is approved by the EPA to combat white mold in soybeans, canola, and dry beans, enhancing yield potential.
14 October 2025
Merus Publishes Abstract on Petosemtamab for Metastatic Colorectal Cancer at AACR-NCI-EORTC Conference
Petosemtamab shows antitumor activity and manageable safety in mCRC trials, with ongoing data updates to be presented at the conference.
14 October 2025
Genmab Reports Q3 2025 DARZALEX Sales of $3.67 Billion
Genmab earns royalties from DARZALEX sales, with $2.09B in the U.S. and $1.58B globally. The company focuses on innovative antibody therapeutics for cancer and serious diseases.
14 October 2025
BP Q3 2025 Trading Update
Upstream production rises, gas trading average, oil trading weak. Asset impairments expected. Net debt stable at $26B. Brent at $69.13/bbl, Henry Hub at $3.07/mmBtu.
13 October 2025
Merus to Present Petosemtamab Data at AACR-NCI-EORTC Conference
Petosemtamab data in metastatic colorectal cancer to be presented in plenary and poster sessions at an upcoming conference.
13 October 2025
Siemens Aids Airbus in Decarbonizing U.S. and UK Sites
By 2030, energy use to drop 20% and CO₂ by 85% at four sites using digital twins, renewable energy, and smart systems. Capgemini aids in consulting and planning.
9 October 2025
Novo Nordisk Acquires Akero Therapeutics to Enhance MASH Treatment Portfolio
Novo Nordisk acquires Akero for $4.7B, adding efruxifermin, a promising MASH treatment, to its portfolio. The deal includes a $0.5B contingent value right upon regulatory approval.
9 October 2025
Johnson Matthey Catalyst Technologies Sale and Trading Update
Catalyst Technologies sale to Honeywell progresses. Strong group profit expected, cash flow improving. Full-year outlook positive, driven by PGM Services.
8 October 2025
ENGEL Group Acquires Trexel for Foaming Technology Expansion
The acquisition enhances foaming tech, ensuring stability and growth. Trexel will operate independently, maintaining quality and service, while contributing to sustainability and market expansion.
8 October 2025
INEOS Chief Urges EU Politicians to Act to Save Chemical Industry
Europe's chemical industry faces decline due to high energy costs and taxes. Urgent policy changes are needed to prevent job losses and increased reliance on imports.
8 October 2025
Sonopress and Indorama Ventures Launch Sustainable EcoRecord® LPs
EcoRecord® LPs use recyclable PET, cutting CO₂ emissions by 85% compared to PVC. Demand for sustainable music formats is rising, with 77% willing to pay more for eco-friendly options.
7 October 2025
LANXESS Innovations at SEPAWA Congress 2025
Showcasing sustainable solutions for personal and home care, including preservatives, oxidizing agents, and biodegradable products, supporting manufacturers' sustainability goals.
7 October 2025
Air Liquide Invests $50M to Expand Hydrogen Supply in U.S. Gulf Coast
Investing $50M to enhance its hydrogen network, the company secures new supply agreements with major U.S. refiners, optimizing existing infrastructure for increased capacity.
7 October 2025
Merck Acquires Verona Pharma
Merck enhances its cardio-pulmonary portfolio with Ohtuvayre, a novel COPD treatment, following the $10 billion acquisition of Verona Pharma.
7 October 2025
BBG Advanced Therapies and CELLforCURE Partner for Transatlantic ATMP Manufacturing Solutions
The partnership enhances global CDMO capacity, offering integrated services for ATMP development and manufacturing, leveraging expertise and infrastructure across the U.S. and Europe.
← Previous
Next →
